Cognitive Development and Cannabis Use in Adolescents.
adolescents
cannabis
cognition
executive functions
working memory
Journal
Behavioral sciences (Basel, Switzerland)
ISSN: 2076-328X
Titre abrégé: Behav Sci (Basel)
Pays: Switzerland
ID NLM: 101576826
Informations de publication
Date de publication:
17 Mar 2021
17 Mar 2021
Historique:
received:
12
01
2021
revised:
02
03
2021
accepted:
09
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Heavy exposure to cannabis during adolescence can cause significant neurocognitive changes. It can alter emotional responsiveness and social behavior, and cause impairments in sustained attention, learning, working memory (WM), cognitive flexibility, and the speed of information processing. It also has a significant impact on executive functions. In this study we investigated how global cognitive functions can be affected by the frequency of cannabinoid consumption in different categories of consumers (chronic, occasional, and non-users), through the evaluation of executive functions. Statistical analysis showed a significant decrease in performance in working memory tasks and processing speed by subjects using cannabis chronically (group 1) as compared to non-consumers (group 3), and occasional consumers (group 2). Future studies could verify the extent of neurocognitive alterations through re-evaluations with controlled follow-up and the addition of neuro-functional data.
Identifiants
pubmed: 33802852
pii: bs11030037
doi: 10.3390/bs11030037
pmc: PMC8002758
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Psychol Med. 2017 Nov;47(15):2708-2719
pubmed: 28558859
Addict Behav. 2008 Jul;33(7):919-33
pubmed: 18355973
Arch Gen Psychiatry. 2008 Jun;65(6):694-701
pubmed: 18519827
J Addict Dis. 2000;19(1):1-22
pubmed: 10772599
J Stud Alcohol Drugs. 2011 Jan;72(1):96-105
pubmed: 21138716
J Neurophysiol. 2007 Sep;98(3):1223-30
pubmed: 17634345
J Neurosci. 1998 Jul 15;18(14):5322-32
pubmed: 9651215
Addict Behav. 2009 Nov;34(11):976-9
pubmed: 19505769
Eur Neuropsychopharmacol. 2007 Mar;17(4):289-97
pubmed: 17137758
Pharmacol Biochem Behav. 2002 May;72(1-2):237-50
pubmed: 11900794
J Cogn Neurosci. 2011 Sep;23(9):2123-34
pubmed: 20809855
Psychopharmacology (Berl). 2011 Jul;216(1):131-44
pubmed: 21328041
Drug Alcohol Depend. 2008 Jan 1;92(1-3):239-47
pubmed: 17888588
Curr Drug Abuse Rev. 2008 Jan;1(1):81-98
pubmed: 19630708
Pharmacol Biochem Behav. 1991 Nov;40(3):683-8
pubmed: 1806953
Neurotoxicol Teratol. 2005 Mar-Apr;27(2):231-9
pubmed: 15734274
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Psychol Addict Behav. 2017 Jun;31(4):423-434
pubmed: 28414475
Arch Gen Psychiatry. 1996 Nov;53(11):1051-7
pubmed: 8911228
Neuroreport. 2001 Dec 21;12(18):3973-8
pubmed: 11742222
Neuropsychol Rev. 2016 Jun;26(2):186-222
pubmed: 27125202
J Stud Alcohol Drugs. 2016 Mar;77(2):298-308
pubmed: 26997188
Ann N Y Acad Sci. 2007 Dec;1121:216-31
pubmed: 17872388
Psychopharmacology (Berl). 2006 Apr;185(3):358-68
pubmed: 16521034
Prev Sci. 2007 Jun;8(2):89-101
pubmed: 17286212
Psychiatry Res. 2008 May 30;163(1):40-51
pubmed: 18356027
Lancet Psychiatry. 2015 Mar;2(3):233-8
pubmed: 26359901
Neuropsychopharmacology. 2008 Oct;33(11):2760-71
pubmed: 18172430
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8174-9
pubmed: 15148381
Annu Rev Neurosci. 2006;29:565-98
pubmed: 16776597
Trends Cogn Sci. 2010 Jun;14(6):277-90
pubmed: 20493761
Drug Alcohol Rev. 2011 Nov;30(6):629-37
pubmed: 21355925
Ann N Y Acad Sci. 2004 Jun;1021:384-90
pubmed: 15251914
Pharmacol Ther. 2015 Apr;148:1-16
pubmed: 25460036
Biol Psychiatry. 2016 Apr 1;79(7):e17-31
pubmed: 26858212
Hum Brain Mapp. 2014 May;35(5):2470-82
pubmed: 24038570
Am J Psychiatry. 2019 Feb 1;176(2):98-106
pubmed: 30278790
Psychopharmacology (Berl). 2010 May;209(4):319-30
pubmed: 20217055
Dev Neuropsychol. 2005;28(2):573-94
pubmed: 16144428
Ann N Y Acad Sci. 2004 Jun;1021:77-85
pubmed: 15251877
Psychol Sci Public Interest. 2006 Sep;7(1):1-44
pubmed: 26158695
Nature. 2006 Mar 30;440(7084):676-9
pubmed: 16572172
Synapse. 2006 Nov;60(6):429-36
pubmed: 16881072
JAMA. 2002 Mar 6;287(9):1123-31
pubmed: 11879109
Biol Psychiatry. 1995 May 15;37(10):731-9
pubmed: 7640328
J Int Neuropsychol Soc. 2012 Jul;18(4):678-88
pubmed: 22613255
N Engl J Med. 2014 Jun 5;370(23):2219-27
pubmed: 24897085
Psychopharmacology (Berl). 2013 Mar;226(2):307-19
pubmed: 23138434
J Neurophysiol. 2008 Dec;100(6):3328-42
pubmed: 18799601
PLoS One. 2013;8(2):e55821
pubmed: 23390554
Dev Psychol. 2005 Jul;41(4):625-35
pubmed: 16060809
Brain Res. 2000 Sep 22;877(2):407-10
pubmed: 10986361
Curr Addict Rep. 2014 Jun 1;1(2):144-156
pubmed: 25013751
J Int Neuropsychol Soc. 2007 Sep;13(5):807-20
pubmed: 17697412
Hippocampus. 2015 Sep;25(9):1042-51
pubmed: 25760303
JAMA. 1996 Feb 21;275(7):521-7
pubmed: 8606472
Curr Pharm Des. 2014;20(13):2138-67
pubmed: 23829361
Biol Psychiatry. 2007 Jan 1;61(1):31-40
pubmed: 16631130
Drug Alcohol Rev. 2007 May;26(3):309-19
pubmed: 17454021